annual CFF:
$6.84M-$18.28M(-72.76%)Summary
- As of today (May 18, 2025), ACAD annual cash flow from financing activities is $6.84 million, with the most recent change of -$18.28 million (-72.76%) on December 31, 2024.
- During the last 3 years, ACAD annual CFF has fallen by -$11.32 million (-62.31%).
- ACAD annual CFF is now -98.72% below its all-time high of $533.81 million, reached on December 31, 2016.
Performance
ACAD Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.84M-$131.00K(-6.65%)Summary
- As of today (May 18, 2025), ACAD quarterly cash flow from financing activities is $1.84 million, with the most recent change of -$131.00 thousand (-6.65%) on March 31, 2025.
- Over the past year, ACAD quarterly CFF has increased by +$795.00 thousand (+76.22%).
- ACAD quarterly CFF is now -99.43% below its all-time high of $319.97 million, reached on September 30, 2019.
Performance
ACAD quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$7.64M+$795.00K(+11.61%)Summary
- As of today (May 18, 2025), ACAD TTM cash flow from financing activities is $7.64 million, with the most recent change of +$795.00 thousand (+11.61%) on March 31, 2025.
- Over the past year, ACAD TTM CFF has dropped by -$17.07 million (-69.08%).
- ACAD TTM CFF is now -98.79% below its all-time high of $629.39 million, reached on September 30, 2019.
Performance
ACAD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ACAD Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.8% | +76.2% | -69.1% |
| 3 y3 years | -62.3% | -25.5% | -40.8% |
| 5 y5 years | -98.2% | -51.0% | -97.9% |
ACAD Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.8% | at low | -85.6% | +585.8% | -69.6% | +11.6% |
| 5 y | 5-year | -98.2% | at low | -96.1% | +585.8% | -98.2% | +11.6% |
| alltime | all time | -98.7% | +1930.2% | -99.4% | +114.7% | -98.8% | +1107.8% |
ACAD Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.84M(-6.7%) | $7.64M(+11.6%) |
| Dec 2024 | $6.84M(-72.8%) | $1.97M(+634.7%) | $6.84M(-33.6%) |
| Sep 2024 | - | $268.00K(-92.5%) | $10.31M(-54.8%) |
| Jun 2024 | - | $3.56M(+241.8%) | $22.79M(-7.7%) |
| Mar 2024 | - | $1.04M(-80.8%) | $24.71M(-1.7%) |
| Dec 2023 | $25.13M(+206.5%) | $5.43M(-57.4%) | $25.13M(+17.9%) |
| Sep 2023 | - | $12.75M(+132.8%) | $21.31M(+140.9%) |
| Jun 2023 | - | $5.48M(+273.7%) | $8.85M(+22.9%) |
| Mar 2023 | - | $1.47M(-9.2%) | $7.20M(-12.2%) |
| Dec 2022 | $8.20M(-54.9%) | $1.61M(+462.4%) | $8.20M(-25.1%) |
| Sep 2022 | - | $287.00K(-92.5%) | $10.95M(-6.6%) |
| Jun 2022 | - | $3.83M(+55.3%) | $11.73M(-9.1%) |
| Mar 2022 | - | $2.47M(-43.5%) | $12.90M(-29.0%) |
| Dec 2021 | $18.16M(-77.6%) | $4.37M(+309.5%) | $18.16M(-43.1%) |
| Sep 2021 | - | $1.07M(-78.7%) | $31.92M(-25.0%) |
| Jun 2021 | - | $5.00M(-35.2%) | $42.57M(-49.9%) |
| Mar 2021 | - | $7.73M(-57.4%) | $84.97M(+4.9%) |
| Dec 2020 | $81.00M(-78.2%) | $18.13M(+54.7%) | $81.00M(-23.5%) |
| Sep 2020 | - | $11.71M(-75.3%) | $105.93M(-74.4%) |
| Jun 2020 | - | $47.40M(+1162.7%) | $414.18M(+11.5%) |
| Mar 2020 | - | $3.75M(-91.3%) | $371.43M(-0.1%) |
| Dec 2019 | $371.85M(+21.3%) | $43.06M(-86.5%) | $371.85M(-40.9%) |
| Sep 2019 | - | $319.97M(+6786.9%) | $629.39M(+103.3%) |
| Jun 2019 | - | $4.65M(+11.3%) | $309.64M(+0.5%) |
| Mar 2019 | - | $4.18M(-98.6%) | $307.94M(+0.4%) |
| Dec 2018 | $306.65M(+883.2%) | $300.60M(>+9900.0%) | $306.65M(+2730.2%) |
| Sep 2018 | - | $211.00K(-92.9%) | $10.84M(-41.5%) |
| Jun 2018 | - | $2.95M(+2.5%) | $18.52M(-18.0%) |
| Mar 2018 | - | $2.88M(-39.9%) | $22.58M(-27.6%) |
| Dec 2017 | $31.19M(-94.2%) | $4.79M(-39.3%) | $31.19M(+2.6%) |
| Sep 2017 | - | $7.90M(+12.7%) | $30.38M(-87.8%) |
| Jun 2017 | - | $7.01M(-39.0%) | $248.56M(-5.2%) |
| Mar 2017 | - | $11.49M(+188.3%) | $262.31M(-50.9%) |
| Dec 2016 | $533.81M(+3581.0%) | $3.99M(-98.2%) | $533.81M(-1.0%) |
| Sep 2016 | - | $226.08M(+989.1%) | $539.16M(+71.6%) |
| Jun 2016 | - | $20.76M(-92.7%) | $314.21M(+6.1%) |
| Mar 2016 | - | $282.99M(+2932.5%) | $296.05M(+1941.5%) |
| Dec 2015 | $14.50M(-92.9%) | $9.33M(+724.4%) | $14.50M(+81.8%) |
| Sep 2015 | - | $1.13M(-56.4%) | $7.98M(-1.8%) |
| Jun 2015 | - | $2.60M(+80.6%) | $8.13M(+12.1%) |
| Mar 2015 | - | $1.44M(-48.7%) | $7.25M(-96.4%) |
| Dec 2014 | $203.85M | $2.81M(+119.0%) | $203.85M(+1.1%) |
| Sep 2014 | - | $1.28M(-25.5%) | $201.67M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $1.72M(-99.1%) | $201.37M(-34.9%) |
| Mar 2014 | - | $198.04M(>+9900.0%) | $309.52M(+177.1%) |
| Dec 2013 | $111.68M(+13.8%) | $629.00K(-35.4%) | $111.68M(-44.8%) |
| Sep 2013 | - | $974.00K(-99.1%) | $202.29M(-2.8%) |
| Jun 2013 | - | $109.87M(>+9900.0%) | $208.17M(+111.6%) |
| Mar 2013 | - | $208.00K(-99.8%) | $98.36M(+0.2%) |
| Dec 2012 | $98.17M(+604.0%) | $91.23M(+1229.9%) | $98.17M(+1295.3%) |
| Sep 2012 | - | $6.86M(>+9900.0%) | $7.04M(+4138.6%) |
| Jun 2012 | - | $57.00K(+159.1%) | $166.00K(+6.4%) |
| Mar 2012 | - | $22.00K(-77.3%) | $156.00K(-98.9%) |
| Dec 2011 | $13.94M(+2866.8%) | $97.00K(-1070.0%) | $13.94M(-1.8%) |
| Sep 2011 | - | -$10.00K(-121.3%) | $14.21M(-2.3%) |
| Jun 2011 | - | $47.00K(-99.7%) | $14.53M(+1.0%) |
| Mar 2011 | - | $13.81M(+3746.8%) | $14.38M(+2960.2%) |
| Dec 2010 | $470.00K(-59.5%) | $359.00K(+12.9%) | $470.00K(-60.4%) |
| Sep 2010 | - | $318.00K(-405.8%) | $1.19M(-5.7%) |
| Jun 2010 | - | -$104.00K(+1.0%) | $1.26M(-1.0%) |
| Mar 2010 | - | -$103.00K(-109.6%) | $1.27M(+9.6%) |
| Dec 2009 | $1.16M(-410.4%) | $1.08M(+176.2%) | $1.16M(-4565.4%) |
| Sep 2009 | - | $390.00K(-528.6%) | -$26.00K(-95.9%) |
| Jun 2009 | - | -$91.00K(-57.7%) | -$634.00K(+48.1%) |
| Mar 2009 | - | -$215.00K(+95.5%) | -$428.00K(+14.4%) |
| Dec 2008 | -$374.00K(-100.4%) | -$110.00K(-49.5%) | -$374.00K(+580.0%) |
| Sep 2008 | - | -$218.00K(-289.6%) | -$55.00K(-164.0%) |
| Jun 2008 | - | $115.00K(-171.4%) | $86.00K(-99.9%) |
| Mar 2008 | - | -$161.00K(-177.0%) | $96.97M(-1.3%) |
| Dec 2007 | $98.22M(+40.3%) | $209.00K(-371.4%) | $98.22M(-0.6%) |
| Sep 2007 | - | -$77.00K(-100.1%) | $98.82M(-0.5%) |
| Jun 2007 | - | $97.00M(+8798.9%) | $99.36M(+59.7%) |
| Mar 2007 | - | $1.09M(+34.1%) | $62.23M(-11.1%) |
| Dec 2006 | $70.00M(+146.7%) | $813.00K(+77.9%) | $70.00M(+23.4%) |
| Sep 2006 | - | $457.00K(-99.2%) | $56.72M(+0.4%) |
| Jun 2006 | - | $59.87M(+576.2%) | $56.51M(+81.7%) |
| Mar 2006 | - | $8.85M(-171.0%) | $31.10M(+9.6%) |
| Dec 2005 | $28.37M(-5.8%) | -$12.47M(-5086.4%) | $28.37M(-30.0%) |
| Sep 2005 | - | $250.00K(-99.3%) | $40.53M(+1.5%) |
| Jun 2005 | - | $34.46M(+462.8%) | $39.94M(+8.0%) |
| Mar 2005 | - | $6.12M(-2096.4%) | $36.99M(+22.9%) |
| Dec 2004 | $30.11M(+14.0%) | -$306.70K(-10.3%) | $30.11M(-1.0%) |
| Sep 2004 | - | -$342.10K(-101.1%) | $30.41M(-1.1%) |
| Jun 2004 | - | $31.51M(-4256.8%) | $30.75M(-4156.8%) |
| Mar 2004 | - | -$758.10K | -$758.10K |
| Dec 2003 | $26.40M(+502.1%) | - | - |
| Dec 2002 | $4.39M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CFF year-on-year change?
- What is ACADIA Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CFF year-on-year change?
- What is ACADIA Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CFF year-on-year change?
What is ACADIA Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ACAD is $6.84M
What is the all time high annual CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual cash flow from financing activities is $533.81M
What is ACADIA Pharmaceuticals annual CFF year-on-year change?
Over the past year, ACAD annual cash flow from financing activities has changed by -$18.28M (-72.76%)
What is ACADIA Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ACAD is $1.84M
What is the all time high quarterly CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly cash flow from financing activities is $319.97M
What is ACADIA Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ACAD quarterly cash flow from financing activities has changed by +$795.00K (+76.22%)
What is ACADIA Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ACAD is $7.64M
What is the all time high TTM CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM cash flow from financing activities is $629.39M
What is ACADIA Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ACAD TTM cash flow from financing activities has changed by -$17.07M (-69.08%)